Who Paid My Doc
ASCEND P3 AD Extension
Research payments
$8,963,658
Through program year 2024, $8,963,658 in research payments was reported against ASCEND P3 AD Extension, across 295 payments, paid by Amgen Inc..
- Paid by
- Amgen Inc.
- ClinicalTrials.gov
- No trial number was reported for this study
By program year
1 row| Year | Kind | Amount | Payments |
|---|---|---|---|
| 2024 | Research | $8,963,658 | 295 |
Breakdown
Usually the institution or organisation running the study, not a person.
Records
Every payment, record by record
Date, amount, who was paid and what for — filter by year and kind, or download as CSV, free, in files of 5,000 rows.
Principal investigators named
10 shownNamed on the study's payments. Being named is not being paid: the money in the figures above went to the recipients listed, not necessarily to these people.
- Stephen Schleicher Sugarloaf, PA Named on 4 payments
- Mark Amster Brighton, MA Named on 4 payments
- Linda Stein Gold West Bloomfield, MI Named on 4 payments
- Carrie Cobb Lynchburg, VA Named on 4 payments
- Dowling Stough Hot Springs, AR Named on 4 payments
- Deborah Nixon Charlotte, NC Named on 3 payments
- Holly Kanavy Bronx, NY Named on 3 payments
- Barbara Baxter Dallas, TX Named on 3 payments
- Sarah Smiley Medford, OR Named on 3 payments
- Kevin Stein Winston Salem, NC Named on 3 payments
What you are looking at
Research payments are tied to a study. Being named on a study as a principal investigator is reported separately from being paid as a recipient, and the two are not the same thing — a named investigator has not necessarily received the money.